Clinical Observation of "xiaojia Decoction" in Treating Postoperative Mammary Carcinoma in 110 Cases

OUYANG Hua-qiang,HUANG Wen-xia,LIU Lu-ming,SONG Ming-zhi
DOI: https://doi.org/10.3969/j.issn.1007-1334.2006.06.024
2006-01-01
Abstract:Objective To observe the efficacy of Xiaojia Decoction in preventing the recurrence and metastasis of postoperative mammary carcinoma. Methods 110 subjects were randomly divided into two groups: treatment group and control group. All subjects were treated with radiotherapy, chemotherapy and endocrine therapy, and cases in the former group were integrated with oral decoction simultaneously. Results In the 74 patients in treatment group, 4 relapsed, 8 metastasized, and 1 patient died; the median disease free survival time(mDFS) for these 13 cases were 6.1 years. In the 36 cases in control group, the mDFS was 3.6 years, P 0.05; and the difference of 10 years mDFS was extremely significant(P 0.01). Conclusion Xiaojia Decoction can prevent and delay the recurrence and metastasis of postoperative mammary carcinoma, along with an improvement in the quality of life.
What problem does this paper attempt to address?